Pompe Disease Market Poised to Grow at a CAGR of 8.4% by 2024

Pompe Disease Market Poised to Grow at a CAGR of 8.4% by 2024


Infinium Global Research has added a new report on Pompe Disease Market. The report presents analysis of global as well as regional markets of pompe disease market over the period of 2016 to 2024.

Pompe disease, is an autosomal recessive metabolic disorder that damages muscle and nerve cells throughout the body. It is caused by an accumulation of glycogen in the lysosome due to deficiency of the lysosomal acid alpha-glucosidase enzyme. These disease approximately affects one individual in 40,000 in the U.S, however the incidence varies among different ethnic group. Pompe disease can be treated by symptomatic, supportive and disease-specific ways. As the disease involves impairment of cardiac, respiratory and muscular systems, the treatment entails requirement of specialists with expertise in all these disorders. Cardiologists, dieticians, pediatricians, orthopedists and other specialist may need to co-ordinate and design a well collaborated treatment plan for the patient.

 

The global Market size of pompe disease Market was worth USD XX million and it is projected to reach to USD XX million by 2024.Increasing developments in the gene therapy and enzyme replacement therapies are the primary factors driving the growth of Pompe disease Market. However, inflated costs associated with the pompe disease therapy could hinder the market growth opportunities. Moreover, research activities performed to find an effective treatment for the disease and the growth in the special regulatory drug designations for orphan drugs can further create the growth opportunities for pompe disease market

 

Among the geographies, North America held the largest market share in 2017 and is expected to hold its dominance in pompe disease market over the forecast period. Asia Pacific is expected to grow at the highest CAGR over the forecast period, owing to increasing awareness about the pompe disease & its treatment procedure and rising healthcare infrastructure in Asia Pacific countries.

 

Moreover, the growth matrix presented by Infinium Global Research identifies the key investment markets in the near future, this will not only help the companies to understand the competitive position in the global pompe disease market  but also make strategic decisions to capture the most lucrative markets in the near future. The market size is presented in terms of value for the historic year 2016 and estimated for forecast period of 2018-2024.

 

Get 15% discount for early purchase of global pompe disease market report by clicking the following link, Use code IGRD15 to request the discount in the given form

https://www.infiniumglobalresearch.com/reports/request-discount/1322

 

The recent report identified that North America dominated the global pompe disease market over the last couple of years, while emerging markets of Asia-Pacific and Latin America are anticipated to contribute significantly to the growth in the pompe disease market worldwide.

 

The report segments the global pompe disease market on the basis of Therapy Type, Molecule Type, Dosage Form and Route of Administration.

 

Global Pompe Disease Market by Therapy Type

·         Enzyme Replacement Therapy

·         Substrate Reduction Therapy

 

Global Pompe Disease Market by Molecule Type

·         Biologics

·         Small Molecules

 

Global Pompe Disease Market by Dosage Form

·         Solid

·         Liquid

 

Global Pompe Disease Market by Route of Administration

·         Oral

·         Parental

 

Companies Profiled in the Report

·         Amicus Therapeutics

·         Biomarin Pharmaceuticals

·         Genzyme

·         Audentes Therapeutics

·         EPIVAX

·         OXYRANE

·         Valerion Therapeutics

·         Sangamo Biosciences

 

About Infinium Global Research

Infinium Global Research is a business intelligence company that provides its clients with market information services, solutions, and reports. The intelligence reports include qualitative as well as quantitative information, which are blended using forecasting models in order to project future market demand. Our panels of Subject Matter Experts (SMEs), Analysts, and Consultants use numerous data gathering tools in order to provide you with detailed information on the market as well as a preview of its projected growth. Our repository includes the largest and most credible databases, through which we determine various qualitative and quantitative parameters of the market to provide you with an in-depth business intelligence report.

Infinium Global Research reports and consulting services cover numerous sectors, which include healthcare, chemicals, materials, energy, packaged goods, food and beverages, technology, and communications. These reports provide readers with market insights and detailed analysis of market segments to possible micro levels. Our reports, with stratified research methodology and wider scope of analysis, provide clients with crucial insights and information to meet their every requirement.


© 2024. Infinium Global Research LLP. All Rights Reserved.